| Asset | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 |
|---|---|---|---|---|---|---|
| Equity | 97.32% | 97.64% | 97.98% | 98.70% | 99.45% | 99.68% |
| Debt | 0.01% | 0.01% | 0.00% | 0.01% | 0.01% | 0.00% |
| Others (incl. cash) | 2.67% | 2.35% | 2.02% | 1.29% | 0.54% | 0.32% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 62,06,349 | 1,235.37 | 13.31% | 0.53%↑ |
| Lupin Ltd. | Healthcare | 27,83,991 | 672.33 | 7.25% | -0.20%↓ |
| Divis Laboratories Ltd. | Healthcare | 7,50,754 | 604.81 | 6.52% | 1.06%↑ |
| Cipla Ltd. | Healthcare | 37,95,054 | 559.09 | 6.03% | -0.12%↓ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 5,48,795 | 491.56 | 5.30% | 0.03%↑ |
| Dr. Reddys Laboratories Ltd. | Healthcare | 40,49,746 | 464.95 | 5.01% | -1.67%↓ |
| Mankind Pharma Ltd. | Healthcare | 14,04,429 | 346.84 | 3.74% | -0.29%↓ |
| Sai Life Sciences Ltd. | Healthcare | 25,55,745 | 336.11 | 3.62% | 0.13%↑ |
| Ajanta Pharma Ltd. | Healthcare | 9,13,918 | 316.69 | 3.41% | -0.05%↓ |
| Max Healthcare Institute Ltd. | Healthcare | 26,58,082 | 291.99 | 3.15% | -0.17%↓ |
| Medplus Health Services Ltd. | Healthcare | 35,45,229 | 249.92 | 2.69% | -0.49%↓ |
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | 9,28,841 | 246.64 | 2.66% | 0.19%↑ |
| Ipca Laboratories Ltd. | Healthcare | 13,64,742 | 238.53 | 2.57% | 0.00% |
| Thyrocare Technologies Ltd. | Healthcare | 40,16,627 | 232.56 | 2.51% | -0.14%↓ |
| Vijaya Diagnostic Centre Ltd. | Healthcare | 16,71,618 | 224.73 | 2.42% | -0.38%↓ |
| Abbott India Ltd. | Healthcare | 74,802 | 207.95 | 2.24% | 0.15%↑ |
| Gland Pharma Ltd. | Healthcare | 8,00,549 | 200.37 | 2.16% | -0.05%↓ |
| Piramal Pharma Ltd. | Healthcare | 99,37,272 | 194.38 | 2.09% | 1.07%↑ |
| Dr. Lal Pathlabs Ltd. | Healthcare | 10,00,578 | 190.63 | 2.05% | 0.20%↑ |
| Alkem Laboratories Ltd. | Healthcare | 3,23,678 | 186.16 | 2.01% | 0.02%↑ |
| Sector | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 97.32% | 97.64% | 97.98% | 98.70% | 99.45% | 99.68% |
31.6 / 100
Weighted average Value score is 31.6. This indicates that portfolio is relatively reasonably valued using composite of value measures.
67.5 / 100
Weighted average Price Momentum score is 67.5. This indicates that portfolio has average momentum using composite of momentum measures.
86.9 / 100
Weighted average Quality score is 86.9. This indicates that portfolio has high quality using composite of quality measures.
73.2 / 100
Weighted average QVM score is 73.2. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
